Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan vs high-dose proton pump inhibitor for prevention of recurrent bleeding in high-risk peptic ulcer
TCTR20210227002Phase 3Unknown
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan in Peptic ulcer disease (PUD), sponsored by Faculty of Medicine, Prince of Songkhla University. Status: unknown.
02
Drugs
vonoprazan
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on TCTR20210227002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210227002.